CAMBER CAPITAL MANAGEMENT LP
Adviser information for CAMBER CAPITAL MANAGEMENT LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 8 |
---|---|
Investment Advisory/Research | 3 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 3 | $3.5B |
Non-Discretionary | 0 | $0 |
Total | 3 | $3.5B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 3 | $3.5B |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 67 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
101 HUNTINGTON AVENUESUITE 2101
BOSTON
MA
United States
Monday - Friday, 8AM-5PM
Tel: 617-717-6600, Fax: 617-717-6688
Websites
Chief Compliance Officer
SEAN GEORGE
CHIEF FINANCIAL OFFICER
101 HUNTINGTON AVENUE
SUITE #2101
BOSTON
MA
United States
Tel:
617-717-6600
Fax:
617-717-6688
S******@****************M
(Full email address available in API data)
Regulatory Contact
JUSTIN KINNEEN
CONTROLLER
101 HUNTINGTON AVENUE
SUITE #2101
BOSTON
MA
United States
Tel:
(617) 717-6612
J*******@****************M
(Full email address available in API data)
Industry Affiliates
None |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
CAMBER CAPITAL MASTER FUND, L.P. | Hedge Fund | $3,542.0M | $1.0M | 196 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
DUBOIS, STEPHEN, RODNEY | Individual | – | MANAGING MEMBER | 02/2006 | > 75% |
FOLEY, BRIAN, JAMES | Individual | – | CHIEF OPERATING OFFICER | 02/2010 | < 5% |
GEORGE, SEAN, JOSEPH | Individual | – | CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER | 02/2010 | < 5% |
CAMBER CAPITAL PARTNERS IV LLC | Domestic Entity | – | GENERAL PARTNER | 03/2018 | < 5% |
DUBOIS, STEPHEN, RODNEY | Individual | CAMBER CAPITAL PARTNERS IV LLC | SOLE OWNER | 03/2018 | > 75% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ANAPTYSBIO INC | COM | 13K | 500K | – |
ARGENX SE | SPONSORED ADR | 31K | 72K | – |
BAXTER INTL INC | COM | 184K | 6M | – |
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 19K | 915K | – |
BIOMARIN PHARMACEUTICAL INC | COM | 91K | 1M | – |
BROOKDALE SR LIVING INC | COM | 106K | 16M | – |
BROOKDALE SR LIVING INC | UNIT 11/15/2025 | 23K | 250K | – |
CUREVAC N V | COM | 2K | 550K | – |
CVS HEALTH CORP | COM | 89K | 2M | – |
DENALI THERAPEUTICS INC | COM | 46K | 2M | – |
EVOLENT HEALTH INC | CL A | 12K | 625K | – |
GENMAB A/S | SPONSORED ADS | 1K | 50K | – |
GLOBUS MED INC | CL A | 171K | 3M | – |
GSK PLC | SPONSORED ADR | 103K | 3M | – |
HERBALIFE LTD | COM SHS | 31K | 3M | – |
HUMANA INC | COM | 149K | 400K | – |
INOGEN INC | COM | 16K | 2M | – |
JAZZ PHARMACEUTICALS PLC | SHS USD | 123K | 1M | – |
MEDTRONIC PLC | SHS | 177K | 2M | – |
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 16K | 355K | – |
MYRIAD GENETICS INC | COM | 135K | 6M | – |
ORASURE TECHNOLOGIES INC | COM | 18K | 4M | – |
PERRIGO CO PLC | SHS | 39K | 2M | – |
PFIZER INC | COM | 70K | 3M | – |
PTC THERAPEUTICS INC | COM | 107K | 4M | – |
QIAGEN NV | SHS NEW | 62K | 2M | – |
REPLIMUNE GROUP INC | COM | 12K | 1M | – |
SAREPTA THERAPEUTICS INC | COM | 24K | 150K | – |
SELECT MED HLDGS CORP | COM | 89K | 3M | – |
SPDR S&P 500 ETF TR | TR UNIT | 952K | 2M | – |
THE BEAUTY HEALTH COMPANY | COM CL A | 7K | 4M | – |
THERAVANCE BIOPHARMA INC | COM | 8K | 1M | – |
UNIVERSAL HLTH SVCS INC | CL B | 176K | 950K | – |
VIATRIS INC | COM | 159K | 15M | – |
WALGREENS BOOTS ALLIANCE INC | COM | 85K | 7M | – |
ZIMMER BIOMET HOLDINGS INC | COM | 209K | 2M | – |
ZIMVIE INC | COM | 59K | 3M | – |